MMA Indications Beyond SDH

Disclosure(s):

Adnan Siddiqui, MD PhD: , Q’Apel Medical, Inc., QAS.ai, Inc., Radical Catheter Technologies, Inc., ReNiva, Inc., Rist Neurovascular, Inc. (Purchased 2020 by Medtronic), Sense Diagnostics, Inc., Serenity Medical, Inc., Sim & Cure, Spinnaker Medical, Inc.,: Stock Options (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); 3N Endovascular, Adona Medical, Inc., Basecamp Vascular SAS, Bend IT Technologies, Ltd., BlinkTBI, Inc, Borvo Medical, Inc., CerebrovaKP, Code Zero Medical, Inc., Cognition Medical, Collavidence, Inc., Contego Medical, Inc., CVAID Ltd., CygnusMed, E8: Stock Options (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Abbott Laboratories, Acandis GmbH, Asahi Intecc Co. Ltd., Canon Medical Systems USA, Inc., Carotix Medical, LLC, CerebrovaKP, Cerenovus, Contego Medical, Inc., Cordis, Endostream Medical, Ltd (recently sold to Kaneka), FreeOx Biotech: Consultant (Ongoing); Endostream Medical, Ltd (Sold 2025 to Kaneka), FreeOx Biotech, SL, Galaxy Therapeutics, Inc., Hyperion Surgical, Inc., Imperative Care, Inc., InspireMD, Ltd., Instylla, Inc., IRRAS, AB,: Stock Options (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Hyperfine Operations, Inc., Imperative Care , InspireMD, Ltd., Integra LifeSciences Corporation, IRRAS AB, Medtronic, Minnetronix Neuro, Inc., Medical Microinstruments, Inc., Peijia Medical, Penumbra, Inc. Perflow Medical, Ltd.,: Consultant (Ongoing); Jacobs Institute: Employee (Ongoing); Launch NY, Inc., Neurolutions, Inc., Neurovascular Diagnostics, Inc., NeXtGen Biologics, Peijia Medical, PerFlow Medical, Ltd., Physician X, LLC, Piraeus Medical, Inc., Prometheus Therapeutics, Inc., PUMA Venture Capital Fund I, LP: Stock Options (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); National PI/Steering Committees: Cerenovus EXCELLENT and ARISE II Trial; Medtronic ARTISSE IDE, SWIFT PRIME, VANTAGE, EMBOLISE and SWIFT DIRECT Trials; Terumo Neuro (formerly MicroVention) FRED Trial & CONFIDENCE Study; MUSC POSITIVE Trial;: Advisor (Ongoing), Board Member/Officer/Trustee (Ongoing), Consultant (Ongoing); National PI/Steering Committees: Penumbra 3D Separator Trial, COMPASS Trial, INVEST Trial, MIVI neuroscience EVAQ Trial; Rapid Medical SUCCESS Trial; InspireMD C-GUARDIANS IDE Pivotal Trial;: Advisor (Ongoing), Board Member/Officer/Trustee (Ongoing), Consultant (Ongoing); Patent No. US 11,464,528 B2, Date: October 11, 2022, CLOT RETRIEVAL SYSTEM FOR REMOVING OCCLUSIVE CLOT FROM A BLOOD VESSEL, Applicant and Assignee: Neuravi Limited (Galway), Role: Co-Inventor: Royalty Recipient (Ongoing); Piraeus Medical, Inc., Prometheus Therapeutics, Inc., Q’Apel Medical, Inc., Serenity Medical, Inc., Shockwave Medical, Inc., Sirtex Medical, Inc., Stryker Neurovascular., Synchron Australia Pty Ltd., Tegus Medical, GmbH,: Consultant (Ongoing); Stent’Up, Synchron, Inc., Tegus Medical, GmbH, T.G. Medical, Inc., Tulavi Therapeutics, Inc., Vastrax, LLC, Viseon, Inc., Viz.ai, Whisper Medical, Inc., Willow Medtech, Inc.: Stock Options (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); T.G. Medical, Inc., Terumo Neuro (Formerly MicroVention), Unity Medical, Inc. Vastrax, LLC, Vesalio, Viz.ai, Inc., WL Gore: Consultant (Ongoing)